It's not an instant solution, and continued use is often needed
S2CID 149445288
Clinically tested for skin irritation
Semax is not FDA-approved for any of the above indications
Phase 1 human trials have been registered in some geographies Published human efficacy data at the level of a completed, results-reported phase 2 study are not yet a settled part of the dataset Commercial development is active but has not produced a near-term approval path Patients and clinicians tracking 5-amino-1MQ should monitor ClinicalTrials.gov and peer-reviewed publications for current status
To date, 78% have been accepted into MD, MD/MBA, MD/PhD, or PhD programs at a variety of institutions across the country, including at Johns Hopkins, Stanford, Vanderbilt, Brown, Albert Einstein, Baylor, Kennesaw State, Duke, Emory, Mayo Clinic Arizona, Ohio State, Tufts, University of Chicago, Georgetown, Harvard, UC Berkeley, UTSW, and Oregon Health Sciences among others